Opendata, web and dolomites

EpiShuttle 2.0 SIGNED

EpiShuttle: Isolation and Transportation of Infectious Disease Patients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EpiShuttle 2.0 project word cloud

Explore the words cloud of the EpiShuttle 2.0 project. It provides you a very rough idea of what is the project "EpiShuttle 2.0" about.

pulmonary    drc    capital    siu    contagious    events    regulatory    million    sius    2014    virus    resistant    founded    ebola    reusable    manner    congo    travelling    transport    engineering    re    compromising    hard    person    outbreaks    people    size    global    economic       polycarbonate    disinfection    first    wants    africa    opportunity    larger    demonstrated    china    infectious    positive    tuberculosis    professionals    care    specialized    treatment    units    disease    group    position    bill    2015    zika    plague    medical    recommends    handle    sars    workflow    eur    company    complete    epishuttle    diseases    brazil    mers    investment    patients    77    risk    plus    society    expand    epidemic    worldwide    cdc    protection    usa    catastrophe    patient    epiguard    12    modern    leap    health    gold    madagascar    market    infected    thousand    doctors    globally    emergency    solution    west    standard    lives    claimed    11    outside    representing    team    patterns    class    combining    faced    isolation    gas    isolate    asia    least    launched    world    risks    partnering    security    labour    clearance   

Project "EpiShuttle 2.0" data sheet

The following table provides information about the project.

Coordinator
EPIGUARD AS 

Organization address
address: TORSNESVEIEN 210
city: GAMLE FREDRIKSTAD
postcode: 1634
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙565˙000 €
 EC max contribution 2˙495˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EPIGUARD AS NO (GAMLE FREDRIKSTAD) coordinator 2˙495˙500.00

Map

 Project objective

The Problem: An increasing number of outbreaks with infectious diseases are seen globally. Ebola has claimed at least 77 lives in DRC (Congo) so far this year and over 11 thousand people West Africa in 2014. Other recent outbreaks are the SARS-epidemic, the MERS-cases in Asia, multi-resistant tuberculosis and the pulmonary Plague epidemic in Madagascar, Zika virus in Brazil, etc. Each of these events demonstrated the large health, economic and security risks associated with infectious disease outbreaks. The travelling patterns of our modern society increases the risk of a global “catastrophe”. To handle outbreaks, the CDC highly recommends the use of specialized isolation units (SIU) to isolate and transport the infected patients. The Solution: EpiGuard was founded in 2015 by a group of medical doctors that faced the challenge of managing Ebola patients on the field. After 3 years and ~5 million EUR of capital and labour investment, the company has recently launched into EU market the EpiShuttle solution – the world-first hard-top (polycarbonate), reusable SIU, representing a leap forward against the state of the art. The EpiShuttle is a one-person SIU, providing complete protection from contagious diseases, without compromising advanced treatment and care to the patient. The Opportunity: Partnering with a world-class design and engineering team, EpiGuard wants to position EpiShuttle as the gold standard for SIUs in the emergency workflow. EpiShuttle targets a 12 Bill. EUR market opportunity worldwide. Although the response from medical professionals has been positive, to fully exploit the market potential, there is a need for combining modern gas disinfection technology with EpiShuttle to allow re-use in a cost effective manner. Further, to expand the market outside Europe, regulatory clearance in USA and China plus a larger size unit for the USA market are needed.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPISHUTTLE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPISHUTTLE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

GUARDIAN (2020)

Eco-friendly smart doors for non-residential building fire protection

Read More